What role does the (2R,6R)-hydronorketamine metabolite play in the antidepressant-like and abuse-related effects of (R)-ketamine?

被引:6
作者
Hillhouse, Todd M. [1 ]
Rice, Remington [2 ]
Porter, Joseph H. [2 ]
机构
[1] Weber State Univ, Dept Psychol, 1299 Edvalson St, Ogden, UT 84408 USA
[2] Weber State Univ, Dept Psychol, Richmond, VA USA
关键词
CONCISE GUIDE;
D O I
10.1111/bph.14785
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:3886 / 3888
页数:3
相关论文
共 21 条
[1]  
Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS272, DOI [10.1111/bph.13877, 10.1111/bph.13882]
[2]   THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels [J].
Alexander, Stephen P. H. ;
Peters, John A. ;
Kelly, Eamonn ;
Marrion, Neil V. ;
Faccenda, Elena ;
Harding, Simon D. ;
Pawson, Adam J. ;
Sharman, Joanna L. ;
Southan, Christopher ;
Davies, Jamie A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 :S130-S159
[3]   THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors [J].
Alexander, Stephen P. H. ;
Christopoulos, Arthur ;
Davenport, Anthony P. ;
Kelly, Eamonn ;
Marrion, Neil V. ;
Peters, John A. ;
Faccenda, Elena ;
Harding, Simon D. ;
Pawson, Adam J. ;
Sharman, Joanna L. ;
Southan, Christopher ;
Davies, Jamie A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 :S17-S129
[4]   (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray [J].
Chou, Dylan ;
Peng, Hsien-Yu ;
Lin, Tzer-Bin ;
Lai, Cheng-Yuan ;
Hsieh, Ming-Chun ;
Wen, Yang-Cheng ;
Lee, An-Sheng ;
Wang, Hsueh-Hsiao ;
Yang, Po-Sheng ;
Chen, Gin-Den ;
Ho, Yu-Cheng .
NEUROPHARMACOLOGY, 2018, 139 :1-12
[5]   Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine [J].
Fukumoto, Kenichi ;
Fogaca, Manoela V. ;
Liu, Rong-Jian ;
Duman, Catharine ;
Kato, Taro ;
Li, Xiao-Yuan ;
Duman, Ronald S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (01) :297-302
[6]   The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY [J].
Harding, Simon D. ;
Sharman, Joanna L. ;
Faccenda, Elena ;
Southan, Chris ;
Pawson, Adam J. ;
Ireland, Sam ;
Gray, Alasdair J. G. ;
Bruce, Liam ;
Alexander, Stephen P. H. ;
Anderton, Stephen ;
Bryant, Clare ;
Davenport, Anthony P. ;
Doerig, Christian ;
Fabbro, Doriano ;
Levi-Schaffer, Francesca ;
Spedding, Michael ;
Davies, Jamie A. .
NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) :D1091-D1106
[7]   Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine [J].
Highland, Jaclyn N. ;
Morris, Patrick J. ;
Zanos, Panos ;
Lovett, Jacqueline ;
Ghosh, Soumita ;
Wang, Amy Q. ;
Zarate, Carlos A., Jr. ;
Thomas, Craig J. ;
Moaddel, Ruin ;
Gould, Todd D. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (01) :12-24
[8]   A Brief History of the Development of Antidepressant Drugs: From Monoamines to Glutamate [J].
Hillhouse, Todd M. ;
Porter, Joseph H. .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2015, 23 (01) :1-21
[9]   Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function [J].
Lumsden, Eric W. ;
Troppoli, Timothy A. ;
Myers, Scott J. ;
Zanos, Panos ;
Aracava, Yasco ;
Kehr, Jan ;
Lovett, Jacqueline ;
Kim, Sukhan ;
Wang, Fu-Hua ;
Schmidt, Staffan ;
Jenne, Carleigh E. ;
Yuan, Peixiong ;
Morris, Patrick J. ;
Thomas, Craig J. ;
Zarate, Carlos A., Jr. ;
Moaddel, Ruin ;
Traynelis, Stephen F. ;
Pereira, Edna F. R. ;
Thompson, Scott M. ;
Albuquerque, Edson X. ;
Gould, Todd D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (11) :5160-5169
[10]   Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine [J].
Shaffer, Christopher L. ;
Dutra, Jason K. ;
Tseng, Wei Chou ;
Weber, Mark L. ;
Bogart, Luke J. ;
Hales, Katherine ;
Pang, Jincheng ;
Volfson, Dmitri ;
Ende, Christopher W. Am ;
Green, Michael E. ;
Buhl, Derek L. .
NEUROPHARMACOLOGY, 2019, 153 :73-81